首页> 外文期刊>Journal of pediatric gastroenterology and nutrition >Adult Liver Disease Prognostic Modelling for Long-term Outcomes in Biliary Atresia
【24h】

Adult Liver Disease Prognostic Modelling for Long-term Outcomes in Biliary Atresia

机译:胆道休息室长期成果的成人肝病预后模型

获取原文
获取原文并翻译 | 示例
           

摘要

ABSTRACT Objectives: To assess the utility of prognostic scoring systems for adolescents with biliary atresia (BA) surviving with native liver, for predicting the subsequent requirement for liver transplantation (LT). Methods: Single-centre retrospective analysis of 397 BA patients who received Kasai Portoenterostomy (KP) 1980–1996 and survived with the native liver at 16?years. Laboratory and clinical variables at 16?years (timepoint 16 years) were used to calculate (i) LT allocation scores; Model for End-Stage Liver Disease [MELD/MELD-sodium (Na)], and UK End-Stage Liver Disease (UKELD); (ii) Mayo Primary Sclerosing Cholangitis risk score (MayoPSC) and (iii) a modified Paediatric End-Stage Liver Disease (PELD) score. Scores were compared between patients requiring LT after 16?years of age (LT >?16 years), and those who survived with native liver, at the latest follow-up. Additional subgroup analysis for patients with data available at 12?years (timepoint 12 years). Results: MELD (area under the receiver operating characteristic [AUROC] 0.847) and UKELD (AUROC: 0.815) at 16?years of age predict the need for LT?>?16 years. No advantage for MELD-Na over MELD was demonstrated. MELD >8.5 and UKELD >47 predicted LT >?16 years with 84% and 79% sensitivity and 73% and 73% specificity. PELD had a similar performance to MELD, but superiority to UKELD. MayoPSC revealed predictive accuracy for LT >16 years (AUROC 0.859), with a score of >0.87 predicting LT >?16 years with 85% sensitivity and 82% specificity. At timepoint 12 years, MELD and MayoPSC predicted LT >16 years. Change in MELD, PELD and MayoPSC between 12 and 16?years of age, was associated with LT >16 years. Conclusions: Adult LT allocation scores may help monitor progress in adolescent BA, but the omission of relevant risk factors limits their utility for listing in this cohort. A BA-specific prognostic score would improve the management of adolescent BA.
机译:摘要目的:评估青少年胆道闭锁(BA)患者使用自体肝存活的预后评分系统的实用性,以预测肝移植(LT)的后续需求。方法:单中心回顾性分析1980-1996年间397例接受Kasai门肠造口术(KP)并在16岁时用自体肝存活的BA患者?年。16岁时的实验室和临床变量?年(时间点16年)用于计算(i)LT分配分数;终末期肝病[MELD/MELD钠(Na)]和英国终末期肝病(UKELD)模型;(ii)梅奥原发性硬化性胆管炎风险评分(MayoPSC)和(iii)改良的儿科终末期肝病(PELD)评分。比较16岁以后需要LT的患者之间的得分?年龄(LT>-16岁),以及在最近的随访中存活下来的肝移植患者。对12岁时有数据的患者进行额外的亚组分析?年(时点12年)。结果:MELD(接收器工作特性下的面积[AUROC]0.847)和UKELD(AUROC:0.815)在16?年龄预测是否需要LT?>?16年。MELD Na对MELD没有优势。MELD>8.5和UKELD>47预测LT>?16年,敏感性和特异性分别为84%和79%、73%和73%。佩尔德的表现与梅尔德相似,但比尤克尔德优越。MayoPSC显示LT>16年的预测准确率(AUROC 0.859),评分>0.87预测LT>?16年,敏感性85%,特异性82%。在12年的时间点,MELD和MayoPSC预测LT>16年。MELD、PELD和MayoPSC在12到16之间的变化?年龄与LT>16岁相关。结论:成人LT分配分数可能有助于监测青少年BA的进展,但相关风险因素的遗漏限制了其在该队列中的实用性。BA特异性预后评分将改善青少年BA的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号